Description

TELAVINCE AF25 is a prescription antiviral medicine containing Tenofovir Alafenamide 25 mg (TAF). It is primarily used for the treatment of chronic Hepatitis B virus (HBV) infection in adults and eligible adolescents. Tenofovir Alafenamide is a newer prodrug of tenofovir that delivers the active medicine more efficiently to liver cells, helping suppress viral replication while using a lower dose than older formulations. This targeted approach provides effective antiviral activity with improved kidney and bone safety in appropriate patients. Chronic Hepatitis B can lead to serious liver complications, including cirrhosis, liver failure, and liver cancer if left untreated. TELAVINCE AF25 helps reduce the amount of hepatitis B virus in the body, protects liver function, and lowers the risk of disease progression. It should always be taken under the supervision of a qualified healthcare professional as part of a long-term treatment plan. Uses of Tenofovir alafenamide 25 mg Treatment of chronic Hepatitis B (HBV) infection Helps reduce hepatitis B viral load Supports improved liver health and function Lowers the risk of liver damage and disease progression Long-term management of chronic HBV under medical supervision Benefits of Tenofovir alafenamide 25 mg Effectively suppresses Hepatitis B virus replication Helps protect the liver from ongoing viral damage Lower dose with targeted delivery to liver cells Better kidney and bone safety profile compared with older tenofovir formulations in suitable patients Convenient once-daily oral tablet Supports long-term viral suppression and improved quality of life Dosage Take TELAVINCE AF25 exactly as prescribed by your doctor. Usually taken once daily with food Swallow the tablet whole with water Take it at the same time each day Do not skip doses or stop treatment without medical advice, as this may worsen Hepatitis B infection Side Effects Common side effects may include: Headache Nausea Fatigue Abdominal discomfort Diarrhea Dizziness Seek immediate medical attention if you experience severe allergic reactions, signs of liver problems, or unusual symptoms during treatment. Precautions and Warnings Use only under medical supervision. Regular liver and kidney function tests may be required. Inform your doctor if you have kidney disease, liver disease, or HIV infection. Pregnancy and breastfeeding should be discussed with your healthcare provider before starting treatment. Do not discontinue the medicine without consulting your doctor, as Hepatitis B may worsen after stopping therapy. Conclusion TELAVINCE AF25 (Tenofovir Alafenamide 25 mg) is an effective antiviral medicine for the long-term management of chronic Hepatitis B infection. By reducing viral replication and protecting liver function, it helps lower the risk of serious liver complications and supports better long-term health. For optimal results, take the medicine exactly as prescribed and attend regular medical follow-up appointments. FAQs 1. What is TELAVINCE AF25 used for? It is used to treat chronic Hepatitis B virus (HBV) infection. 2. What is the active ingredient in TELAVINCE AF25? It contains Tenofovir Alafenamide 25 mg. 3. How does Tenofovir Alafenamide 25 mg work? It blocks the replication of the Hepatitis B virus, reducing the viral load in the body. 4. Is TELAVINCE AF25 taken every day? Yes, it is usually taken once daily with food, as prescribed by your doctor. 5. What are the common side effects of TELAVINCE AF25? Headache, nausea, fatigue, diarrhea, dizziness, and abdominal discomfort. 6. Can I stop taking TELAVINCE AF25 on my own? No. Stopping treatment without medical advice may cause Hepatitis B to worsen. 7. Does TELAVINCE AF25 require a prescription? Yes. It is a prescription-only antiviral medicine and should be used under medical supervision.